JANICE REED: Open Payments
NPI 1902036999 · BALL GROUND, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$842 in 35 payments from 9 companies in 2025. Trend: 2023 $650 · 2024 $560 · 2025 $842
Food & beverage: $842
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $311 |
| PFIZER INC. | 8 | $222 |
| ABBVIE INC. | 5 | $126 |
| Lilly USA, LLC | 3 | $50 |
| Exact Sciences Corporation | 2 | $40 |
| Axsome Therapeutics, Inc. | 1 | $30 |
| Eisai Inc. | 1 | $27 |
| AstraZeneca Pharmaceuticals LP | 1 | $22 |
| Hikma Pharmaceuticals USA | 1 | $14 |
Products named: Wegovy, NURTEC ODT, QULIPTA, Ozempic, Cologuard Collection Kit, KISUNLA, VRAYLAR, Symbravo.
Industry payments across GA — which companies pay providers there.
